{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:51:41Z","timestamp":1790833901526,"version":"4.1.0"},"reference-count":16,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> According to WHO, in 2017, about 90.5 million people suffered from\ncancer and about 8.8 million deaths occurred due to disease. Although the chemotherapeutic\nagents have decreased the mortality among the cancer patients but high toxicity and non-specific\ntargets are still major drawbacks.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Many researchers have identified linomide, a 4-hydroxy-2-quinolone derivative, as a lead molecule for\nthe development of anticancer agents. With this background, we thought of the following objective.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of this research work involves the synthesis of a series of N-(2-(4-\nhydroxy-2-oxo-1-phenyl-1,2-dihydroquinolin-3-yl)-2-oxoethyl)-N-alkyl substituted benzene\nsulfonamides IVa-d (1-3) by replacing the anilide moiety at the third position of linomide with\nsulfamoylacyl and also N-methyl by N-phenyl functionality. To perform in silico anticancer activity\nby using Molegro Virtual Docker (MVD-2013, 6.0) software and in vitro anticancer activity\nby MTT assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The starting material 4-hydroxy-1-phenylquinolin-2(1H)-one was treated with N-bromosuccinamide\nto yield compound II. Condensation of compound II with primary amines resulted in\ncompounds IIIa-d, which, on coupling with substituted aromatic sulfonyl chlorides yield the title\ncompounds IVa-d (1-3).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>All the synthesized compounds were satisfactorily characterized by spectral data. The results\nof docking revealed that the synthesized compounds exhibited well-conserved hydrogen\nbonds with one or more amino acid residues in the active pocket of EGFRK tyrosine kinase domain\n(PDB ID: 1m17). The MolDock Score of compound IVd-1 (-115.503) was the highest\namongst those tested. The in vitro anticancer activity results showed that compound IVc-1 (R= -\n(CH2) 2-CH3 ; R\u2032= -H) and IV d-1 (R= -CH2-C6H5; R\u2032= -H) were found to be most potent against\nK562 cell line with an IC50 of 0.451 \u03bcM\/ml and 0.455 \u03bcM\/ml respectively. Compound IVd-1 also\nshowed better potency against A549 cell line with IC50 value of 0.704 \u03bcM\/ml.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results of in silico and in vitro anticancer activity are in agreement with each other.\nCompound IV d-1 was found to be most active of the series.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163815666181008151037","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T11:33:29Z","timestamp":1539257609000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design, Synthesis, and Characterization of Novel Linomide Analogues and their Evaluation for Anticancer Activity"],"prefix":"10.2174","volume":"17","author":[{"given":"Rudrax N.S.","family":"Priolkar","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, PES\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Shingade","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, PES\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Palkar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, KLEU\u2019s College of Pharmacy, Hubli, Karnataka 580031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivalingrao M.","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, PES\u2019s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa 403401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin 2011,61(2),69-90","journal-title":"CA Cancer J Clin"},{"key":"ref=2","unstructured":"Facts and Figures[(Accessed on 09\/06\/2017).]"},{"key":"ref=3","first-page":"819","author":"Tripathi K.D.","year":"2006","unstructured":"Tripathi K.D.;  sixth ed New\n Delhi: Jaypee Brothers Medical Publishers (P) Ltd pp. ((reprint 2010)):2006,819-29","journal-title":"sixth ed New\n Delhi: Jaypee Brothers Medical Publishers (P) Ltd"},{"key":"ref=4","author":"Block J.H.","year":"2011","unstructured":"Block J.H.; Beale J.M.;  Wilson and Gisvold\u2019s Medicinal and Pharmaceutical Chemistry 2011","journal-title":"Wilson and Gisvold\u2019s Medicinal and Pharmaceutical Chemistry"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0014-827X(99)00030-0","volume":"54","author":"Thomas K.","year":"1999","unstructured":"Thomas K.; The pyrano route to 4-hydroxy-2-quinolones and 4-hydroxy-2-pyridones. IL Farmaco 1999,54,309-315","journal-title":"IL Farmaco"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0968-0896(02)00526-6","volume":"11","author":"Zhang Q.","year":"2003","unstructured":"Zhang Q.; Chen Y.; Zheng Y.Q.; Xia P.; Xia Y.; Yang Z.Y.; Bastow K.F.; Morris-Natschke S.L.; Lee K.H.; Synthesis and bioactivity of 4,10-dimethyl-pyridino[2,3-h]quinolin-2(1H)-one-9-carboxylic acid and its esters. Bioorg Med Chem 2003,11(6),1031-1034","journal-title":"Bioorg Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1016\/j.bmc.2012.07.039","volume":"20","author":"Ohashi T.","year":"2012","unstructured":"Ohashi T.; Oguro Y.; Tanaka T.; Shiokawa Z.; Shibata S.; Sato Y.; Yamakawa H.; Hattori H.; Yamamoto Y.; Kondo S.; Miyamoto M.; Tojo H.; Baba A.; Sasaki S.; Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors. Bioorg Med Chem 2012,20(18),5496-5506","journal-title":"Bioorg Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","volume":"97","author":"Afzal O.","year":"2015","unstructured":"Afzal O.; Kumar S.; Haider M.R.; Ali M.R.; Kumar R.; Jaggi M.; Bawa S.; A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem 2015,97,871-910","journal-title":"Eur J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(92)90065-C","volume":"212","author":"Ogino K.","year":"1992","unstructured":"Ogino K.; Hobara T.; Ishiyama H.; Yamasaki K.; Kobayashi H.; Izumi Y.; Oka S.; Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992,212(1),9-13","journal-title":"Eur J Pharmacol"},{"key":"ref=10","first-page":"131","volume":"26","author":"Trinquand C.","year":"2003","unstructured":"Trinquand C.; Romanet J.P.; Nordmann J.P.; Allaire C.; [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].2003,26(2),131-136","journal-title":"J Fr Ophtalmol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881111408461","volume":"26","author":"De Fruyt J.","year":"2012","unstructured":"De Fruyt J.; Deschepper E.; Audenaert K.; Constant E.; Floris M.; Pitchot W.; Sienaert P.; Souery D.; Claes S.; Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis. J Psychopharmacol (Oxford) 2012,26(5),603-617","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=12","first-page":"1254","volume":"55B","author":"Maria G.R.","year":"2016","unstructured":"Maria G.R.; Shivlingrao M.D.; Soniya N.; Synthesis and evaluation of 2-(4-methoxy-2-oxo-1-phenyl\/methyl-1,2-dihydroquinolin-3-yl)-2-methyl-3-(phenyl\/substitutedphenylamino)thiazolidin-4-one as antibacterial and anticancer agents. Indian J Chem 2016,55B,1254-1258","journal-title":"Indian J Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0960-894X(03)00047-7","volume":"13","author":"Shi J.","year":"2003","unstructured":"Shi J.; Xiao Z.; Ihnat M.A.; Kamat C.; Pandit B.; Hu Z.; Li P.K.; Structure-activity relationships studies of the anti-angiogenic activities of linomide. Bioorg Med Chem Lett 2003,13(6),1187-1189","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.bmcl.2005.02.062","volume":"15","author":"Li Q.","year":"2005","unstructured":"Li Q.; Woods K.W.; Wang W.; Lin N.H.; Claiborne A.; Gu W.Z.; Cohen J.; Stoll V.S.; Hutchins C.; Frost D.; Rosenberg S.H.; Sham H.L.; Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors. Bioorg Med Chem Lett 2005,15(8),2033-2039","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.virusres.2008.01.003","volume":"134","author":"Jochmans D.","year":"2008","unstructured":"Jochmans D.; Novel HIV-1 reverse transcriptase inhibitors. Virus Res 2008,134(1-2),171-185","journal-title":"Virus Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.bmc.2014.03.043","volume":"22","author":"Palkar M.B.","year":"2014","unstructured":"Palkar M.B.; Singhai A.S.; Ronad P.M.; Vishwanathswamy A.H.; Boreddy T.S.; Veerapur V.P.; Shaikh M.S.; Rane R.A.; Karpoormath R.; Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Bioorg Med Chem 2014,22(10),2855-2866","journal-title":"Bioorg Med Chem"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/166047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T08:26:51Z","timestamp":1598689611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/166047\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163815666181008151037","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}